0.0575
price down icon42.50%   -0.0425
after-market Dopo l'orario di chiusura: .06 0.0025 +4.35%
loading
Precedente Chiudi:
$0.10
Aprire:
$0.0676
Volume 24 ore:
413.42K
Relative Volume:
0.35
Capitalizzazione di mercato:
$697.73K
Reddito:
-
Utile/perdita netta:
$-48.85M
Rapporto P/E:
-0.0249
EPS:
-2.31
Flusso di cassa netto:
$-46.25M
1 W Prestazione:
-79.09%
1M Prestazione:
-90.09%
6M Prestazione:
-99.24%
1 anno Prestazione:
-99.68%
Intervallo 1D:
Value
$0.0451
$0.084
Intervallo di 1 settimana:
Value
$0.0451
$0.2185
Portata 52W:
Value
$0.0451
$18.70

Vincerx Pharma Inc Stock (VINC) Company Profile

Name
Nome
Vincerx Pharma Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-01
Name
Ultimi documenti SEC
Name
VINC's Discussions on Twitter

Confronta VINC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VINC
Vincerx Pharma Inc
0.0575 697.73K 0 -48.85M -46.25M -2.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-01-14 Iniziato H.C. Wainwright Buy
2021-12-23 Iniziato Cantor Fitzgerald Overweight
2021-11-01 Iniziato SVB Leerink Outperform
2021-09-13 Iniziato Laidlaw Buy
2021-08-25 Iniziato B. Riley Securities Buy

Vincerx Pharma Inc Borsa (VINC) Ultime notizie

pulisher
Apr 23, 2025

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Apr 22, 2025
pulisher
Apr 21, 2025

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Apr 21, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Apr 17, 2025
pulisher
Apr 16, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 16, 2025
pulisher
Apr 16, 2025

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Apr 16, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

Apr 12, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Apr 12, 2025
pulisher
Apr 11, 2025

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

Apr 11, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025
pulisher
Apr 09, 2025

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan

Apr 08, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 28, 2025

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 25, 2025

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 19, 2025

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Mar 19, 2025
pulisher
Mar 19, 2025

Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI -March 18, 2025 at 09:40 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma plans reverse merger with QumulusAI - Investing.com India

Mar 18, 2025

Vincerx Pharma Inc Azioni (VINC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):